Cardiovascular Disease
Showing 51 - 75 of 930
The Miami Heart Study at Baptist Health South Florida
Active, not recruiting
- Cardiovascular Disease
-
Miami, FloridaRaul Herrera
Jun 8, 2022
Cardiovascular Disease, Atherosclerosis, Coronary Artery Disease Trial in Houston (Comprehensive therapy program for risk factor
Active, not recruiting
- Cardiovascular Disease
- +3 more
- Comprehensive therapy program for risk factor modification
-
Houston, TexasWeatherhead PET Center, Memorial Hermann Hospital TMC
May 20, 2022
Cancer, Cardiovascular Disease Trial in Boston (vitamin D3, omega-3 fatty acids (fish oil), Vitamin D3 )
Active, not recruiting
- Cancer
- Cardiovascular Disease
- vitamin D3
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
May 18, 2022
Sleep, Cardiovascular Disease, Obesity Trial in New York (Sleep Restriction)
Completed
- Sleep
- +2 more
- Sleep Restriction
-
New York, New YorkNew York Obesity Nutrition Research Center
May 11, 2022
Cardiovascular Disease Cohort in Guangdong Province
Active, not recruiting
- Cardiovascular Disease
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University
May 3, 2022
Soluble ST2 and Cardiovascular Outcome
Recruiting
- Cardiovascular Disease
- soluble ST2
-
Nanjing, Jiangsu, ChinaThe first affiliated hospital of nanjing medical university
Apr 15, 2022
Cardiovascular Disease Trial in Nanjing (Inspiratory Muscle Training)
Recruiting
- Cardiovascular Disease
- Inspiratory Muscle Training
-
Nanjing, Jiangsu, ChinaThe first affiliated hospital of nanjing medical university
Apr 15, 2022
Assessment of Risk (CLEAR) Study
Completed
- Cardiovascular Disease
-
Box Hill, Victoria, Australia
- +3 more
Apr 11, 2022
Developing the Family Map: Looking at Communal Coping
Recruiting
- Sickle Cell
- +4 more
-
Bethesda, Maryland
- +1 more
Apr 7, 2022
Cardiovascular Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Fx-5A peptide complex)
Recruiting
- Cardiovascular Disease
- Fx-5A peptide complex
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 7, 2022
Chronic Kidney Disease, Cardiovascular Disease, Inflammation Trial in Gainesville (MRI carotid, APWV, Hydroxychloroquine)
Recruiting
- Chronic Kidney Disease
- +4 more
- MRI carotid
- +3 more
-
Gainesville, FloridaNorth Florida/South Georgia Veterans Health System, Gainesville,
Apr 5, 2022
Cardiovascular Disease Trial in Boston (Vitamin D3 + fish oil/fish oil , Vitamin D3 + fish oil/fish oil )
Completed
- Cardiovascular Disease
- Vitamin D3 + fish oil/fish oil placebo
- Vitamin D3 placebo + fish oil/fish oil placebo
-
Boston, MassachusettsMassachusetts General Hospital
Apr 5, 2022
Lifestyle and Cardiometabolic Risk in Post-9/11 Veterans
Recruiting
- PTSD
- +2 more
-
Boston, MassachusettsVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Mar 7, 2022
Cardiovascular Disease Trial in Boston (Result disclosure)
Enrolling by invitation
- Cardiovascular Disease
- Result disclosure
-
Boston, MassachusettsVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Mar 8, 2022
Cardiovascular Disease, HIV Trial in Durham (Telephone, Educational pamphlets)
Active, not recruiting
- Cardiovascular Disease
- HIV
- Telephone
- Educational pamphlets
-
Durham, North CarolinaDuke University Medical Center
Mar 3, 2022
Fernald Community Cohort -18 Year Observational Study
Active, not recruiting
- Cancer
- +3 more
-
Cincinnati, OhioUniversity of Cincinnati
Mar 1, 2022
Aging, Exercise, Cardiovascular Disease Trial in Baltimore (Exercise Training, Exercise Cessation)
Active, not recruiting
- Aging
- +2 more
- Exercise Training
- Exercise Cessation
-
Baltimore, MarylandUniversity of Maryland, Baltimore & Baltimore VA Medical Center
Feb 28, 2022
Cardiovascular Disease, Stroke, Primary Prevention Trial in Yibin (The strategic use of messages in risk communication)
Completed
- Cardiovascular Disease
- +2 more
- The strategic use of messages in risk communication
-
Yibin, Sichuan, ChinaHealth center of Sipo town
Mar 9, 2022
Cardiovascular Disease Trial in Nieuwegein (Low-dose DSA (83% reduction compared to normal dose) with novel X-ray imaging
Completed
- Cardiovascular Disease
- Low-dose DSA (83% reduction compared to normal dose) with novel X-ray imaging technology.
- Normal dose DSA with conventional X-ray imaging technology
-
Nieuwegein, NetherlandsSt. Antonius Ziekenhuis
Mar 7, 2022
Cardiovascular Disease Trial run by the NHLBI (Rosuvastatin, Atorvastatin)
Active, not recruiting
- Cardiovascular Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 5, 2022
Cardiovascular Disease, Acute Coronary Syndrome Trial in United States (Multifaceted Intervention with pharmacist and IVR)
Completed
- Cardiovascular Disease
- Acute Coronary Syndrome
- Multifaceted Intervention with pharmacist and IVR
-
Aurora, Colorado
- +14 more
Feb 8, 2022
Cardiovascular Disease Trial in Boston (SLCO1B1 Genotype)
Completed
- Cardiovascular Disease
- SLCO1B1 Genotype
-
Boston, MassachusettsVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Feb 17, 2022
Cardiovascular Disease Trial in Ottawa (PiezoRx medical grade pedometer)
Completed
- Cardiovascular Disease
- PiezoRx medical grade pedometer
-
Ottawa, Ontario, Canada
- +1 more
Feb 8, 2022
Passive Limb Movement: A Tool to Assess Vascular Health and
Recruiting
- Aging
- Cardiovascular Disease
-
Salt Lake City, UtahVA Salt Lake City Health Care System, Salt Lake City, UT
Jan 24, 2022